Astellas Offers $1 Billion For CV Therapeutics

January 27, 2009 10:40 AM |

Japanese drug maker Astellas Pharma offered approximately $1 billion to acquire CV Therapeutics Inc. (Nasdaq: CVTX).  The stock price leaped $4.62 to $15.97.

Tags:

Search

About this Entry

This page contains a single entry by published on January 27, 2009 10:40 AM.

Delta Posts Massive Loss was the previous entry in this blog.

Earnings Surge For Netflix is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 5.12